Alx Oncology Holdings Inc

NASDAQ:ALXO  
77.81
-3.10 (-3.83%)
Earnings Announcements

ALX Oncology Reports Second Quarter 2021 Financial Results

Published: 08/12/2021 22:11 GMT
Alx Oncology Holdings Inc (ALXO) - Alx Oncology Reports Second Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights.
Q2 GAAP Loss per Share $0.40.
Q2 Earnings per Share Estimate $-0.43 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.49

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.58

More details on our Analysts Page.